SubHero Banner
Text

February 2020

Core topics in this month’s edition include:

  • Nurtec ODT (rimegepant) - new drug approval
  • Pataday Once Daily Relief (olopatadine) and Pataday Twice Daily Relief (olopatadine) - new prescription to over-the-counter approvals
  • Belviq, Belviq XR (lorcaserin) - drug withdrawal

Download PDF

Text